发明名称 Viral inhibitor composition for in vivo therapeutic use
摘要 <p>The present invention concerns a pharmaceutical composition comprising a compound of formula A being (2,3(dihydroxy), 5[3(1,2)butadiene], 1(3hydroxy,3methyl,4pentene) benzene) and/or a compound of formula B being (2,3(dihydroxy), 5[3(1,2)butadiene], 2[2methylbutane] benzenal) and/or a compound of formula C being (2,3(dihydroxy), 5[3(1,2)butadiene], 2hydroxy,3butene benzoate) or a combination thereof for use as a medicament or for in vivo use in treatment and prevention of diseases caused by DNA enveloped viruses, DNA non- enveloped viruses, RNA enveloped viruses and RNA non-enveloped viruses.</p>
申请公布号 AU2011306879(A1) 申请公布日期 2013.10.10
申请号 AU20110306879 申请日期 2011.09.27
申请人 CESA ALLIANCE S.A. 发明人 COPPENS, CHRISTINE
分类号 A61K31/12;A61K31/216;A61P31/12 主分类号 A61K31/12
代理机构 代理人
主权项
地址